Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$38.65 - $43.48 $2.78 Million - $3.12 Million
-71,845 Reduced 61.37%
45,224 $1.81 Million
Q1 2024

May 15, 2024

BUY
$42.85 - $63.45 $5.02 Million - $7.43 Million
117,069 New
117,069 $5.14 Million
Q3 2023

Nov 14, 2023

BUY
$45.51 - $65.0 $636,775 - $909,480
13,992 New
13,992 $643,000
Q4 2022

Feb 14, 2023

BUY
$27.93 - $31.27 $1.23 Million - $1.37 Million
43,937 New
43,937 $1.23 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.64B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.